FIELD: medicine; biochemistry.
SUBSTANCE: invention relates to the field of biomedicine, to multimodal anti-cancer drugs for personalized medicine, in particular to the cyanoporphyrazine free base and its use as a photosensitizer and simultaneously as an optical sensor of intracellular viscosity. 
.
EFFECT: technical result is a total increase in the photodynamic activity of macrocycles while maintaining a high viscous sensitivity of their fluorescence parameters, necessary for their use as a potential noninvasive optical sensor of intracellular viscosity.
17 cl, 5 dwg, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PHOTODYNAMIC THERAPY WITH EFFICIENCY CONTROL IN REAL TIME MODE | 2017 |
|
RU2672806C1 |
| PORPHYRAZINE, GADOLINIUS PORPHYRAZINE COMPLEX AND THEIR APPLICATION | 2016 |
|
RU2621710C1 |
| TETRA(PYREN-1-YL)TETRACYANOPORPHYRAZINE AS A MULTIFUNCTIONAL AGENT FOR THERAPY OF MALIGNANT GROWTHS | 2019 |
|
RU2725641C1 |
| TETRA(BENZOTHIOPHEN-2-YL)TETRACYANOPORPHYRAZINE AS MULTIMODAL PHOTODYNAMIC THERAPY AGENT | 2018 |
|
RU2684623C1 |
| METHOD FOR ASSESSING THE CONTENT OF HYDROGEN PEROXIDE IN TUMOR CELLS IN PHOTODYNAMIC EXPOSURE | 2018 |
|
RU2700421C1 |
| LOW-MOLECULAR DERIVATIVES OF CARBOXAMIDE HALOGENATED PORPHYRINS, SPECIFICALLY CHLORINES AND BACTERIOCHLORINS, AND USE THEREOF | 2016 |
|
RU2718923C2 |
| 2-AMINOBENZOTHIAZOLS AS INVERS AGONIST OF CB RECEPTORS | 2004 |
|
RU2344132C2 |
| PHOTOSENSIBILIZING AGENT, LIPOSOMAL FORMULATION OF PHOTOSENSIBILIZING AGENT AND METHOD FOR CARRYING OUT PHOTODYNAMIC THERAPY | 2004 |
|
RU2257898C1 |
| ALPHA-ARYL-N-ALKYLNITRONES, PHARMACEUTICAL COMPOSITIONS (VARIANTS), METHOD FOR INHIBITION OF NEURODEGENERATIVE DISEASES, METHOD FOR TREATMENT AND METHODS FOR PROPHYLAXIS (VARIANTS) | 1998 |
|
RU2225392C2 |
| SUBSTANCE WITH ANTI-GLIOMA ACTIVITY AND METHOD OF PHOTODYNAMIC THERAPY OF GLIOBLASTOMA | 2022 |
|
RU2794666C1 |
